Agilon Health, Inc. (NYSE:AGL) Receives $2.71 Average PT from Analysts

Agilon Health, Inc. (NYSE:AGL – Get Free Report) has received an average rating of “Hold” from the eighteen analysts that are covering the firm, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, twelve have assigned a hold recommendation and four have given a buy recommendation to the company. The average twelve-month price objective among analysts that have covered the stock in the last year is $2.7083.

AGL has been the subject of a number of research analyst reports. Royal Bank Of Canada upgraded Agilon Health from a “hold” rating to a “moderate buy” rating in a report on Wednesday, December 3rd. Zacks Research upgraded Agilon Health from a “strong sell” rating to a “hold” rating in a research note on Tuesday, October 21st. BTIG Research reissued a “neutral” rating on shares of Agilon Health in a report on Friday, December 12th. Barclays cut their price target on Agilon Health from $1.50 to $1.00 and set an “underweight” rating for the company in a report on Thursday, November 6th. Finally, Wells Fargo & Company reduced their price objective on shares of Agilon Health from $1.50 to $1.00 and set an “overweight” rating for the company in a research report on Wednesday, November 5th.

Read Our Latest Stock Analysis on AGL

Agilon Health Trading Up 17.7%

NYSE AGL opened at $0.82 on Friday. Agilon Health has a 12 month low of $0.51 and a 12 month high of $6.08. The stock has a 50 day moving average of $0.68 and a 200-day moving average of $1.18. The company has a market cap of $337.88 million, a PE ratio of -1.09 and a beta of 0.05.

Agilon Health (NYSE:AGL – Get Free Report) last issued its earnings results on Tuesday, November 4th. The company reported ($0.27) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.09). The firm had revenue of $1.44 billion for the quarter, compared to analyst estimates of $1.43 billion. Agilon Health had a negative return on equity of 75.92% and a negative net margin of 5.24%. As a group, sell-side analysts predict that Agilon Health will post -0.59 EPS for the current fiscal year.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the stock. Wealth Enhancement Advisory Services LLC boosted its holdings in shares of Agilon Health by 5.6% during the second quarter. Wealth Enhancement Advisory Services LLC now owns 105,324 shares of the company’s stock worth $256,000 after acquiring an additional 5,627 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Agilon Health by 3.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock worth $927,000 after purchasing an additional 7,209 shares during the last quarter. Dynamic Technology Lab Private Ltd boosted its stake in Agilon Health by 28.4% in the 1st quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after purchasing an additional 10,424 shares during the period. MetLife Investment Management LLC boosted its stake in Agilon Health by 6.5% in the 1st quarter. MetLife Investment Management LLC now owns 185,870 shares of the company’s stock valued at $805,000 after purchasing an additional 11,319 shares during the period. Finally, Signaturefd LLC grew its holdings in Agilon Health by 65.1% in the 2nd quarter. Signaturefd LLC now owns 30,479 shares of the company’s stock valued at $70,000 after buying an additional 12,018 shares in the last quarter.

Trending Headlines about Agilon Health

Here are the key news stories impacting Agilon Health this week:

• Negative Sentiment: Multiple law firms have filed or announced investigations seeking to represent investors in a securities class action related to allegedly misleading statements and disclosures for purchases between Feb. 26, 2025 and Aug. 4, 2025 — increasing the chance the claims will be consolidated and a lead plaintiff appointed. AGL Investors Have Opportunity to Lead agilon health, inc. Securities Fraud Lawsuit First Filed by the Rosen Law Firm
• Negative Sentiment: Pomerantz LLP issued an investor alert reminding shareholders of the class action and upcoming deadlines for investors who suffered losses to contact the firm. This increases public attention and encourages participation in the suit. INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in agilon health, inc. of Class Action Lawsuit and Upcoming Deadlines – AGL
• Negative Sentiment: Bronstein, Gewirtz & Grossman announced a class action against AGL and certain officers, widening the roster of firms pursuing claims. Bronstein, Gewirtz & Grossman LLC Urges agilon health, inc Investors to Act: Class Action Filed Alleging Investor Harm
• Negative Sentiment: The Schall Law Firm reminded investors of an action alleging violations of Sections 10(b) and 20(a) and Rule 10b-5 — standard securities-fraud claims that, if consolidated, could lead to significant defense and settlement exposure. AGL Investors Have Opportunity to Lead agilon health, inc Securities Fraud Lawsuit with the Schall Law Firm
• Negative Sentiment: Faruqi & Faruqi and several other firms (Bragar Eagel & Squire, Robbins LLP, DJS Law Group) have issued alerts or investigations; Faruqi specifically notes a March 2, 2026 deadline to seek lead-plaintiff status — a timetable investors should monitor. INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of agilon health
• Negative Sentiment: Additional firm notices and filings (Bragar Eagel & Squire, Robbins LLP, DJS Law Group) have been circulated, amplifying publicity and potential plaintiff participation. AGILON ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against Agilon Health, Inc.

About Agilon Health

(Get Free Report)

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.

Read More

• Five stocks we like better than Agilon Health
• Elon Taking SpaceX Public! $100 Pre-IPO Opportunity!
• Do not delete, read immediately
• A U.S. “birthright” claim worth trillions – activated quietly
• This stock gets a 94 out of 100
• BNZI: BNZI Surges Ahead as AI Marketing Fuels Record Revenue